ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Safety"

  • 2022 American Transplant Congress

    Two-Week Protocol Biopsy in Renal Allograft: Feasibility, Safety, and Outcomes

    M. Lim1, K. Lee2

    1Samsung Medical Center, Seoul, Korea, Republic of, 2Department of Surgery, Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: Protocol biopsy in renal allograft helps to early detect subclinical rejection (SCR) in patients who have no abnormal clinical and laboratory findings. Still, there…
  • 2022 American Transplant Congress

    OPTN Required SARS-CoV-2 Lower Respiratory Testing for Lung Donors: Early Impact on Patient Safety and Organ Utilization

    S. E. Booker1, C. Martinez1, C. Fox1, C. Jett1, D. Klassen1, L. Danziger-Isakov2, R. M. La Hoz3

    1UNOS, Richmond, VA, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3University of Texas Southwestern Medical Center, Dallas, TX

    *Purpose: The OPTN implemented emergency policy on 5/27/21 requiring lower respiratory testing (LRT) by nucleic acid test (NAT) for SARS-CoV-2 (COVID-19) for all potential deceased…
  • 2022 American Transplant Congress

    Safety and Efficacy of Early Central Line Removal in Post Liver Transplant Patients

    T. Shamaa1, E. MacLean1, O. Shamaa2, Z. Lu1, A. Hinge3, S. Saymuah3, A. Mohamed4, T. Kitajima4, S. Nagai4, M. Rizzari4, A. Yoshida4, M. Abouljoud4, K. Collins4

    1General Surgery, Henry Ford Hospital, Detroit, MI, 2Internal Medicine, Henry Ford Hospital, Detroit, MI, 3Wayne State University School of Medicine, Detroit, MI, 4Henry Ford Transplant Institute, Detroit, MI

    *Purpose: Avoiding central line-associated infections (CLABSIs) is paramount in liver transplant recipients. As a hospital-wide infection control initiative at our institution, early removal of central…
  • 2022 American Transplant Congress

    Single Port Robotic Kidney Transplantation: Comparison of Outcomes with Standard Open Kidney Transplantation

    M. Eltemamy, A. Kaviani, Y. Lin, M. Abou Zeinab, V. Krishnamurthi, D. Goldfarb, J. Kaouk, A. Wee

    Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH

    *Purpose: To compare outcomes of the initial series of patients who underwent single port (SP) robotic kidney transplantation (KTP) with the standard open KTP.*Methods: Using…
  • 2022 American Transplant Congress

    Patient-Reported Barriers to Living Kidney Donor Follow-Up

    B. Orandi, R. Reed, H. Qu, G. Owens, S. Brooks, C. Killian, V. Kumar, S. Sheikh, R. Cannon, C. Lewis, J. Locke

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Despite regulations mandating follow-up laboratory testing for living kidney donors, less than half of transplant centers are in compliance. We sought to understand barriers…
  • 2022 American Transplant Congress

    Donor-Derived Carbapenem-Resistant Gram-Negative Infections: Risk Mitigation Strategy in Solid Organ Transplant Improves Recipients Safety and Could Expand Donor Pool

    A. Mularoni1, E. Graziano1, M. Campanella1, A. Cervo2, M. Peghin3, F. Barbera1, P. Conaldi1, A. Luca1, P. A. Grossi4

    1ISMETT, Palermo, Italy, 2Department of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy, 3Division of Infectious Diseases, ASUFC, Udine, Italy, 4Infectious and Tropical Diseases Unit, University of Insubria, Varese, Italy

    *Purpose: We implemented an Active Surveillance System (ASS) to mitigate the risk of unexpected carbapenem-resistant Gram-negative (CRGN) donor-derived infection (DDI) in solid organ transplant recipient…
  • 2022 American Transplant Congress

    Patient and Provider Perspectives on Telehealth Clinic Visits Precipitated by the Covid-19 Viral Pandemic

    L. Adamski1, C. Alvarez1, M. Patterson2, C. Shen3, G. Kaur3, F. K. Butt3

    1Penn State College of Medicine, Hershey, PA, 2University of South Carolina, Greenville, SC, 3Penn State Milton S Hershey Medical Center, Hershey, PA

    *Purpose: The transplant community had to adjust to a new way of practicing medicine during the COVID-19 viral pandemic. Our transplant center quickly adapted to…
  • 2022 American Transplant Congress

    Impact of Dysgeusia on Transplant Recipients with Refractory Cytomegalovirus with/without Resistance Receiving Maribavir: Post-Hoc Analyses from a Phase 3 Randomized Trial

    F. Silveira1, S. Haider2, D. Kaul3, O. Witzke4, J. Gu5, A. Sundberg5

    1Univ. Pittsburgh, Pittsburgh, PA, 2McMaster Univ., Hamilton, ON, Canada, 3Univ. Michigan, Ann Arbor, MI, 4Univ. Duisburg-Essen, Essen, Germany, 5Takeda Development Center Americas, Inc., Lexington, MA

    *Purpose: In a Phase 3 study (SOLSTICE; NCT02931539), maribavir (MBV) was superior to investigator-assigned therapies (IAT; val/ganciclovir, foscarnet, or cidofovir) for CMV clearance at Wk…
  • 2022 American Transplant Congress

    Efficacy and Safety of Denosumab on Osteoporosis in Kidney Transplant Recipients

    W. Park, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han

    Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea, Republic of

    *Purpose: The use of immunosuppressive agents, especially glucocorticoids, are associated with increased risks of bone loss in kidney transplant recipients (KTRs). Denosumab, a potent antiresorptive…
  • 2022 American Transplant Congress

    Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Pediatric Kidney and Liver Transplant Recipients

    T. Kitano1, K. Schwartz2, M. Abdulnoor1, H. Garfield3, N. K. Booran1, Y. Avitzur1, C. Teoh1, D. Hebert4, U. Allen3

    1Hospital for Sick Children, Toronto, ON, Canada, 2Public Health Ontario, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada

    *Purpose: Solid-organ transplant recipients are at increased risk of developing human papillomavirus (HPV)-related diseases. The immunogenicity of HPV vaccine for solid-organ transplant population needs further…
  • 1
  • 2
  • 3
  • …
  • 19
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2023 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences